Use of granulocyte-macrophage colony stimulating factor in the treatment of prolonged haematopoietic dysfunction after chemotherapy alone or chemotherapy plus bone marrow transplantation

By Dierdorf Rainier   Kreuter Ulrich   Jones Thomas  

Medical Oncology, Vol. 14, Iss. 2, 1997-06 ,pp. : 91-98

Humana Press, Inc

Access to resources Recommend Favorite

Possible Influence of Granulocyte Colony-Stimulating Factor and Recombinant Human Erythropoietin on Human Chorionic Gonadotropin Secretion during Chemotherapy for Choriocarcinoma - To the Editor

By Losch A.   Lahodny J.   Petru E.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 165-166

Elsevier

Access to resources Recommend Favorite

Treatment of Poor Prognosis Epidemic Kaposi's Sarcoma with Doxorubicin, Bleomycin, Vindesine and Recombinant Human Granulocyte-Monocyte Colony Stimulating Factor (rh GM-CSF)

By Bakker P.J.M.   Danner S.A.   Napel C.H.H.t.   Kroon F.P.   Sprenger H.G.   van Leusen R.   Meenhorst P.L.   Muusers A.   Veenhof C.H.N.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 188-192

Elsevier

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor After Combined Chemotherapy in High-grade Non-Hodgkin's Lymphoma--a Randomised Pilot Study

By Bergmann L.   Karakas T.   Knuth A.   Lautenschlager G.   Mitrou P.S.   Hoelzer D.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2164-2168

Elsevier

Access to resources Recommend Favorite